A combination of exogenous surfactant and partial liquid ventilation (PLV) with per¯uorocar-bons should enhance gas exchange, improve respiratory mechanics and reduce tissue damage of the lung in acute lung injury (ALI). We used a small dose of exogenous surfactant with and without PLV in an experimental model of ALI and studied the effects on gas exchange, haemodynamics, lung mechanics, and lung pathology. ALI was induced by repeated lavages (Pa O 2 /FI O 2 less than 13 kPa) in 24 anaesthesized, tracheotomized and mechanically ventilated (FI O 2 1.0) juvenile pigs. They were treated randomly with either a single intratracheal dose of surfactant (50 mg kg ±1 , Curosurf â , Serono AG, Mu Ènchen, Germany) (SURF-group, n=8), a single intratracheal dose of surfactant (50 mg kg ±1 , Curosurf â ) followed by PLV with 30 ml kg ±1 of per¯uoro-carbon (PF 5080, 3M, Germany) (SURF-PLV-group, n=8) or no further intervention (controls, n=8). Pulmonary gas exchange, respiratory mechanics, and haemodynamics were measured hourly for a 6 h period. In the SURF-group, the intrapulmonary right-to-left shunt (Q Ç S/Q Ç T) decreased signi®cantly from mean 51 (SEM 5)% after lavage to 12 (2)%, and Pa O 2 increased signi®cantly from 8.1 (0.7) to 61.2 (4.7) kPa compared with controls and compared with the SURF-PLV-group (P<0.05). In the SURF-PLV-group, Q Ç S/Q Ç T decreased signi®cantly from 54 (3)% after induction of ALI to 26 (3)% and Pa O 2 increased signi®cantly from 7.2 (0.5) to 30.8 (5.0) kPa compared with controls (P<0.05). Static compliance of the respiratory system (C RS ), signi®cantly improved in the SURF-PLV-group compared with controls (P<0.05). Upon histological examination, the SURF-group revealed the lowest total injury score compared with controls and the SURF-PLV-group (P<0.05). We conclude that in this experimental model of ALI, treatment with a small dose of exogenous surfactant improves pulmonary gas exchange and reduces the lung injury more effectively than the combined treatment of a small dose of exogenous surfactant and PLV. De®ciency of alveolar surfactant, pulmonary hypertension, intrapulmonary right-to-left shunting, and poor arterial oxygenation are features of both experimental acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS).
tidal volumes of 6 ml kg ±1 , a positive end-expiratory pressure (PEEP) level above the lower in¯ection point, and a peak inspiratory pressure below the upper in¯ection point may protect against this effect. 2 6 Other treatments to reduce the mechanical shear stress of the lung include surfactant replacement, 7±11 partial liquid ventilation (PLV), 12±17 and extracorporal membrane oxygenation (ECMO). 18 Giving surfactant may reduce surface tension, improve gas exchange and lung mechanics. 7±11 In PLV the lung is partially ®lled with a per¯uorocarbon and conventional mechanical ventilation is resumed. PLV can improve gas exchange and lung mechanics without signi®cantly affecting systemic circulation.
12±17
Exogenous surfactant and PLV have been investigated using different doses and different experimental models of ALI. 19±29 The effects on gas exchange, haemodynamics, lung mechanics, and lung damage were variable.
A combination of 100 mg kg ±1 of surfactant with PLV, restored pulmonary gas exchange more ef®ciently in an experimental model of neonatal ALI than surfactant therapy alone. However, a combination of PLV with only 5 mg kg ±1 of surfactant failed to give additional bene®t compared with PLV alone. 27 29 We compared a single dose of 50 mg kg ±1 surfactant alone vs 50 mg kg ±1 surfactant combined with PLV in a pig model of ALI, with measurements of gas exchange, haemodynamics, respiratory mechanics, and progression of lung injury.
Methods
This study was approved by the Berlin Animal Protection Committee in accordance with German Animal Protection Law, and conforms with the Guide for the Care and Use of Laboratory Animals (DHHS, PHS, NIH Publication No. 85-23).
General experimental procedures
We studied 24 piglets (weight 23±27 kg), aged between 6 and 8 weeks. Anesthesia was induced with thiopental (10 mg kg ±1 i.v.) and fentanyl (10 mg kg ±1 i.v. followed by an infusion of 0.05±0.08 mg kg ±1 min ±1 ). Muscle relaxation was obtained with pancuronium bromide (0.15 mg kg ±1 i.v. bolus, followed by a continuous infusion of 2.5 mg kg ±1 min ±1 ). Immediately after induction, the pigs were tracheotomized and intubated with a 9.0 mm outer diameter tracheal tube, ®tted with a heat and moisture exchanger.
The animals were placed supine and ventilated in a volume controlled mode (tidal volume 10±12 ml kg ±1 , respiratory rate 16 min ±1 , FI O 2 1.0, I:E ratio 1:1, PEEP 5 cm H 2 O) with an EVITA 2 model 76 ventilator (Dra Èger, Lu Èbeck, Germany). Core temperature was maintained within T0.5°C of the pre-study value using a heating pad. No drugs were used to support the circulation.
We placed a pulmonary artery catheter (model 93A-431-7.5 Fr, Baxter Healthcare Corporation, Irvine, CA, USA) percutaneously via the femoral vein, and an arterial cannula (18 G; Vygon, Ecouen, France) into the femoral artery, for blood sampling and haemodynamic measurements. Heart rate (HR), central venous pressure (CVP), mean arterial pressure (MAP), mean pulmonary artery pressure (MPAP), and pulmonary artery wedge pressure (PCWP) were recorded using a Hewlett-Packard monitoring system (Model 66 S, Bo Èblingen, Germany). Measurements were taken with pigs in the supine position with zero at the level of the midaxilla. Vascular pressures were the average taken at end-expiration of three successive respiratory cycles. Cardiac output (CO) was determined by thermodilution using the mean of four measurements (10 ml saline at 1±5°C) arbitrarily performed during different phases of the respiratory cycle. Intrapulmonary shunt (Q Ç S/Q Ç T), systemic vascular resistance (SVR), and pulmonary vascular resistance (PVR) were calculated using standard formulae.
All blood samples (arterial and mixed venous) were collected anaerobically, and analysed within 5 min (ABL 520, Radiometer, Copenhagen, Denmark). Arterial oxygen saturation (Sa O 2 ) and mixed venous oxygen saturation (Sv O 2 ) were measured by spectrophotometry with the analyser calibrated with pig blood (OSM 3 Hemoximeter, Radiometer). Static compliance of the respiratory system (C RS ) was determined using automated inspiratory, repetitive occlusions (1 s) at single volume steps (SCASS). 30 Measurements started with 10 ml Vt up to a maximum Vt of 10±12 ml kg ±1 , using volume steps of 10 ml each. C RS was calculated as mean of all generated pressure±volume curves from the inspiratory limb.
Lung tissue from all animals was examined histologically. After killing the animals, the tracheal tube was clamped at end-expiration (PEEP 5 cm H 2 O) and the lungs were removed. Per¯uorocarbon was left in situ in animals treated with PLV. Tissues were ®xed in 5% formalin. Specimens from the cranial ventral (non-dependent) and caudal dorsal (dependent) lobes were stained with haematoxylin and eosin and then scored using a semiquantitative scoring system by an experienced veterinary pathologist (A. S-K.), blinded to treatment, for interstitial in®ltration, interstitial oedema, emphysema, and atelectasis. Each variable was scored using a 0±4-point scale, with no injury scored 0, injury in 25% of the ®eld scored 1, injury in 50% of the ®eld scored 2, injury in 75% of the ®eld scored 3, and injury throughout the ®eld scored 4. The total score maximum was 16.
Induction of ALI
Repeated lavage with warmed isotonic saline (37°C) was done to produce lung surfactant depletion as reported by Lachmann and co-workers, and described in detail elsewhere. 31 32 Induction of ALI was assumed when the Pa O 2 / FI O 2 ratio was persistently less than 13 kPa for 1 h.
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Experimental procedure
After induction of ALI, the animals were randomly assigned to receive a single intratracheal dose of surfactant alone (50 mg kg ±1 , Curosurf â ) (SURF-group, n=8), or a single intratracheal dose of surfactant (50 mg kg ±1 ), followed after 30 min by 30 ml kg ±1 of per¯uorocarbon (PF 5080, 3M, Germany) (SURF-PLV-group, n=8), or no further intervention (controls, n=8). Evaporative losses of PF 5080 were replaced at a dose of 4 (3) ml kg ±1 every hour as previously found by our group. 33 PF 5080 (C 8 F 18 ) is a non-ozone-depleting PFC with boiling point 102°C, density (at 25°C) 1.76 g ml ±1 , viscosity (at 25°C) 1.4 cp, vapour pressure (at 37°C) 6.8 kPa, solubility of oxygen (at 37°C) 49 ml 100 ml ±1 , solubility of carbon dioxide (at 37°C) 176 ml 100 ml ±1 , and surface tension (at 25°C) of 15 dyn s cm ±1 (information taken from 3M data sheet). Curosurfâ is isolated from minced pig lungs and contains 99% lipids, mainly phospholipids, and 1% low molecular weight hydrophobic apoproteins SP-B and SP-C. 16 
Statistical analysis
Results are expressed as mean (SEM). The data were obtained at baseline (pre-lavage), immediately after the induction of ALI (post-lavage) and at hourly intervals for 6 h thereafter. Statistical analysis was performed using SPSS for Windows 8.0 and Sigmastat (SPSS Inc., Chicago, IL, USA). Differences between groups were evaluated using Kruskal±Wallis ANOVA followed by post hoc comparisons with Dunn's test (intergroup comparison). The Friedman test was used to compare the data after induction of ALI with the data measured during the subsequent 6 h (intragroup comparison). For post hoc testing, Dunn's test also was applied. Statistical signi®cance was assumed at P<0.05.
Results
All animals were comparable with regard to body weight and pre-study conditions. Pre-lavage data of pulmonary gas exchange, lung compliance, and haemodynamics did not differ signi®cantly between groups (Tables 1 and 2) .
In all animals, induction of ALI increased Q Ç S/Q Ç T concomitant with a decrease in Pa O 2 . Cardiac output (CO), mean pulmonary artery pressure (MPAP), and pulmonary vascular pressure (PVR) increased while mean arterial blood pressure (MABP), and systemic vascular resistance (SVR) decreased (Tables 1 and 2) . Table 1 Time course of HR, MABP, MPAP, CO, SVR, and PVR during baseline (pre-lavage), after induction of ALI (post-lavage), and for 6 h thereafter, in controls (n=8 at ALI; four pigs died before 6 h after ALI), in pigs treated with a single intratracheal dose of 50 mg kg ±1 of surfactant (Curosurf Exogenous surfactant and PLV
Gas exchange
Surfactant alone improved Pa O 2 from 8.1 (0.7) kPa after onset of ALI to 61.2 (4.7) kPa after 6 h of treatment (P<0.05 vs controls; Fig. 1 , Table 2 ). The increase of Pa O 2 in the SURF-group was greater than the increase in the SURF-PLV-group after 6 h of treatment (P<0.05 vs SURF-PLV; Fig. 1 , Table 2 ). In the PLV-SURF-group the increase of Pa O 2 from 7.2 (0.5) kPa after onset of ALI to 30.8 (5.0) kPa after 6 h of treatment was greater than in controls (P<0.05 vs controls; Fig. 1 , Table 2 ). In the SURF group Q Ç S/Q Ç T decreased signi®cantly compared with controls (51 (5)% at onset of ALI to 12 (2)% 6 h after treatment, P<0.05 vs controls; Fig. 2, Table 2 ). In the SURF-PLV-group Q Ç S/Q Ç T was signi®cantly decreased compared with controls (54 (4)% at onset of ALI to 26 (3)% after 6 h of treatment, P<0.05 vs controls; Fig. 2 , Table 2 ).
Haemodynamics
There were no signi®cant changes between groups in HR, MABP, and SVR. In the SURF-group the MPAP increased from 25 (1) mm Hg at onset of ALI to 30 (3) mm Hg after 6 h of treatment, and was signi®cantly less than in controls and in the SURF-PLV-group (P<0.05 vs controls and vs SURF-PLV; Fig. 3 
Lung mechanics
After induction of ALI, static compliance of the respiratory system decreased from 22 (2) ml cm H 2 O ±1 in all groups to 9 (1) ml cm H 2 O ±1 . No further changes of C RS occurred in the SURF-group. In the SURF-PLV-group, C RS improved signi®cantly compared with controls from 9 (1) to 15 (0.4) ml cm H 2 O ±1 at 6 h of treatment (P<0.05 vs controls; Fig. 4 , Table 2 ).
Lung injury
The non-dependent lobes in the SURF-group had a signi®-cantly smaller injury score for interstitial oedema and emphysema compared with controls and the SURF-PLV- 
, static compliance of the respiratory system (C RS ), and survivors during baseline (pre-lavage), after induction of ALI (post-lavage), and for 6 h thereafter, in controls (n=8 at ALI; four pigs died before 6 h after ALI), in pigs treated with a single intratracheal dose of 50 mg kg ±1 Table 3 ). In the SURF-PLV-group, scores for interstitial oedema were signi®cantly greater compared with controls in the non-dependent lobes (P<0.05, Table 3 ).
Comparing tissue damage in dependent lobes, the SURFgroup had signi®cantly less atelectasis and emphysema than controls (P<0.05) and less interstitial oedema and emphysema than the SURF-PLV-group (P<0.05, Table 3 ). In the SURF-PLV-group, interstitial in®ltration and atelectasis of the dependent lobes was less than in controls and the SURFgroup (P<0.05 vs controls and vs SURF), while interstitial oedema and emphysema in the dependent lobes in the SURF-PLV-group was greater than in controls and the SURF-group (P<0.05, Table 3 ). The overall lung injury score of the SURF-group was less in the non-dependent lobes, compared with the SURF-PLVgroup and controls (P<0.05, Table 3 ).
Survival
All animals in both treatment groups survived to the end of the study. In the control-group, four animals died of irreversible hypoxaemia during the study, one after 3 h, two after 4 h, and one 5 h after induction of ALI (Table 2 ).
Discussion
In this study, we compared the effects of a single, small dose of surfactant alone and combined with a full dose of PLV on oxygenation, haemodynamics, respiratory mechanics, and lung injury in an animal model of ALI. A small dose of surfactant was better than a combined treatment with a small dose of surfactant and PLV to restore gas exchange. Respiratory mechanics were only improved in the group treated with the combination of surfactant and PLV. Atelectasis, interstitial oedema, and emphysema were signi®cantly less in the surfactant group than in controls. Compared with the group receiving surfactant and PLV, the surfactant group had a signi®cant smaller total lung injury score.
Surfactant therapy combined with PLV has been studied in different types of ALI. 19 29 Studies have been done in surfactant de®cient pre-term animals, 19 24 26 29 isolated lungs of pre-term animals, 23 27 newborn animals with ALI induced by surfactant wash-out, 21 25 27 and experimental ALI in adult animals. 20 22 Criteria for onset of ALI after surfactant wash-out was a Pa O 2 /FI O 2 ratio below 8 kPa (60 mm Hg), with the exception of the studies by Hartog and co-workers and Kelly and co-workers, who used a value below 13 kPa (100 mm Hg) to indicate ALI. 20 22 The duration of Pa O 2 /FI O 2 less than 8 kPa of 30 min to indicate the induction of ALI was speci®ed only in one study. 21 Our lavage procedure caused a stable Pa O 2 /FI O 2 ratio of 7.6 (0.6) kPa (57 (5) mm Hg) for at least 1 h after the last lavage. The severity of the lung injury in our animals resembles surfactant de®cient pre-term animals, shown by the high shunt fraction, which was 54 (4)% after lung injury.
Mrozek and co-workers compared four different treatments in newborn piglets, after induction of ALI. One group received 100 mg kg ±1 surfactant, one group received PFC in a dose equivalent to the functional residual capacity, one group received PFC 30 min after surfactant replacement, and one group received surfactant 30 min after instillation of PFC. 27 In contrast to our ®nding that a single dose of surfactant caused the greatest improvement in Pa O 2 , Mrozek and colleagues found that a combination of surfactant and PLV was better than the effect of surfactant alone on gas exchange, lung mechanics, and lung pathology. They make no comment on the decrease in Pa O 2 after instillation of PFC in the group treated with PLV after surfactant replacement.
These differences could be attributed to the following: (1) different timepoints of measurement, (2) the use of a bovine surfactant (Survanta), (3) a higher dose of surfactant (100 mg kg ±1 ), (4) newborn piglets as study subjects, and (5) the use of pre-oxygenated per¯ubron (LiquiVent). Another difference was positioning the animals while ®lling the lungs with PFC, which might have allowed greater per¯uorocarbon dose and a more homogenous distribution of PFC throughout the lungs, although this technique appears to be impractical under clinical circumstances. In a study of ALI induced in premature lambs, Leach and coworkers compared either surfactant replacement, a combination of surfactant replacement and PLV, or PLV alone. 29 In this study, a very small dose (5 mg kg ±1 ) of an arti®cial surfactant (Exosurf) did not improve oxygenation and respiratory mechanics when compared with conventional ventilation. The combination of surfactant and PLV was not better than PLV alone. Leach and co-workers attributed the lack of surfactant ef®cacy to the small dose used and to the modest physiologic activity of synthetic surfactant, which gives a greater surface tension than natural surfactant. 29 In our study, improvements in oxygenation and intrapulmonary right-to-left shunt were delayed in the SURF-PLVgroup. This could have been because: (1) PLV was started 30 min after surfactant was instilled, to avoid wash-out of exogenous surfactant; (2) inhomogeneous surfactant distribution could have caused PFC to only enter some regions and, thereby, limit alveolar recruitment. Leach and coworkers describe a transient increase in the expiratory resistance of their surfactant-PLV group and suggested that the distal movement of per¯uorocarbons could have been delayed, as surfactant will remain in small airways and alveolar ducts. 27 In a study from Go Èthberg and co-workers using a model of premature ALI, the treatment of PLV combined with conventional ventilation or combined with high-frequency oscillatory ventilation (HFOV) 2 h after giving 100 mg kg ±1 of surfactant (Infasurf) improved oxygenation compared with treatment with surfactant and conventional ventilation alone. 17 HFOV after surfactant replacement improved Pa O 2 to a similar extent than HFOV combined with PLV and was signi®cantly more effective than PLV and conventional ventilation. The different results of a treatment with PLV and conventional ventilation after surfactant replacement, compared with our data, might be because of different models, a different PFC, a later application of PFC, and different doses of surfactant. Improvement in oxygenation with HFOV, with and without PLV, could be explained by changes in airway pressures and the development of a high intrinsic PEEP from the ventilatory pattern. Previous studies showed that combining PFC and high levels of PEEP enhances the effects of PLV on pulmonary gas exchange.
15±17
The improvement in C RS in our piglets treated with the combination of surfactant and PLV supports the ®ndings of other investigators, and appears to be dose dependent. 9 13 20 We measured the static compliance of the respiratory system, with an inspiratory shutter technique, to exclude effects of PFC vapour-pressure on expiratory volumes. We used 30 ml kg ±1 of per¯uorocarbon, approximately the functional residual capacity of healthy lungs and added further liquid according to our past observations. 33 Tu Ètu Èncu È and co-workers compared the effects of PLV with 18 ml kg ±1 PFC with PLV using 18 ml kg ±1 saline, in a similar model of ALI in rabbits, and found that compliance of the respiratory system increased in the PFC group. 13 Studying adult rabbits with induced ALI, Kelly and colleagues compared the effects of different treatments. 20 The treatments were PLV with 20 ml kg ±1 PFC, nebulized PFC, 100 mg kg ±1 arti®cial surfactant (ALEC), 100 mg kg ±1 porcine surfactant (Curosurf â ), the combination of PLV and ALEC, the combination of PLV and Curosurf â , and a control group. Our observations support their ®ndings for arterial oxygenation. Regarding lung mechanics, 100 mg kg ±1 of Curosurf â improved compliance as effectively as the combination of PLV and Curosurf â . In our study, the smaller dose of exogenous surfactant, was not suf®cient to improve lung mechanics. Kelly and co-workers point out that surfactant from animals contains surfactant apoproteins, which prevent inhibition of surfactant by protein-rich uid in lungs after induction of ALI, and that this effect is dose-dependent. 20 In studies in humans, lung compliance decreases after surfactant treatment, despite increases in functional residual capacity and improvements in oxygenation. This could be because of slow recruitment of atelectatic lung areas, with stabilization of the initially opened lung units. 34 35 Lack of improvement in lung compliance after surfactant administration in experimental ALI was also found by Mrozek and co-workers. 27 We consider that the small dose of surfactant used in our study did not entirely overcome surfactant inhibition, and that the amount of lung tissue opened up in the SURF-group, although suf®cient to improve gas exchange, was not suf®cient to produce effects on C RS .
Treatment with surfactant alone caused less histological injury, for interstitial oedema, atelectasis, and emphysema compared with controls and compared with the SURF-PLVgroup. Comparing the overall lung injury scores between groups, treatment with surfactant alone caused less damage in non-dependent lobes compared with controls and the SURF-PLV-group. A small dose of surfactant reduces the in¯ammatory response in ALI, prevents further atelectasis, and improves gas exchange. The effects on in¯ammation could be attributed to the apoproteins of natural surfactant, which might prevent in¯ammation. The greater lung injury scores in the SURF-PLV-group contrasts with previous results of Mrozek and co-workers, who found least injury with the combined treatment. 27 They suggest that the lower inspiratory pressures needed for effective alveolar ventilation could be the reason for less lung injury in this group. The different PFC used for PLV and a higher dose of surfactant could account for these differences. In rats with lavage-induced ALI, Hartog and colleagues compared lung injury after treatment with surfactant, PLV, and high values of PEEP vs healthy controls and injured controls. 22 Surfactant prevented progression of lung injury, when compared with healthy controls, and PLV increased lung tissue injury compared with healthy controls.
In our study, we found that cardiac output decreased signi®cantly during the study in both treatment groups, which has not been reported previously in short term studies of lavage-induced lung injury. 26 36 37 However, D O 2 and V Ç O 2 remained unchanged in both groups, indicating maintenance of a suf®cient oxygen delivery. A possible explanation for the lower values of CO might be reduced sympathic activity in both treatment groups because of better oxygenation. This view is supported by poorer survival in control animals. As suggested by Dantzker and co-workers, a reduction in CO could reduce the intrapulmonary right-toleft shunt. 38 The magnitude of this mechanism of shunt Table 3 Lung injury score of the non-dependent and the dependent lobes for atelectasis, interstitial in®ltration, interstitial oedema, emphysema, and total lung injury score in controls (n=8 at ALI; four pigs died before 6 h after ALI), in pigs treated with a single intratracheal dose of 50 mg kg ±1 of surfactant (Curosurf â ) after induction of ALI (SURF-group) (n=8 pigs, none died), and in pigs treated with a single intratracheal dose of 50 mg kg ±1 of surfactant (Curosurf â ) followed by PLV with 30 ml kg ±1 of per¯uorocarbon (PF 5080) after induction of ALI (SURF-PLV-group) (n=8 pigs, none died). Data are mean (SEM). Exogenous surfactant and PLV reduction with a CO reduction of 40% in the SURF-group and 30% in the SURF-PLV-group, suggests that this would only partly account for the reduction found, and indicate other mechanisms, such as alveolar recruitment, could be involved.
The increase in MPAP in animals treated with the combination of surfactant and PLV could be caused by the PFC. In a study from Morris and co-workers healthy pigs had their lungs ®lled with 40 ml kg ±1 of per¯uorocarbons and were conventionally ventilated. 35 Pulmonary blood ow was diverted from the dependent regions of the lung, associated with an increase in MPAP. The authors suggested that a greater hydrostatic pressure gradient in PFC-®lled alveoli, compared with the gradient in the blood vessels, could cause this effect. 37 In conclusion, using an experimental model of ALI in piglets, we found that treatment with a single small dose of surfactant improved oxygenation, decreased intrapulmonary right-to-left shunt, and reduced lung tissue damage more effectively than a combination of surfactant with PLV. However, only the combined treatment of exogenous surfactant and PLV improved lung mechanics. Taken with other evidence, these ®ndings show that further research is needed to ®nd the least dose of surfactant that is effective.
